X4 Pharmaceuticals (XFOR) Treasury Shares (2017 - 2025)
X4 Pharmaceuticals (XFOR) posted Treasury Shares of $73381.0 for Q4 2025, down 26.05% on a QoQ basis from $99232.0 in Q3 2025, and down 63.12% year-over-year from $198995.0 in Q4 2024.
X4 Pharmaceuticals (XFOR) Treasury Shares (2017 - 2025) Analysis & Trends
X4 Pharmaceuticals' Treasury Shares history runs 8 years deep, the most recent figure standing at $73381.0 for Q4 2025.
- Quarterly Treasury Shares fell 63.12% year-over-year to $73381.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $73381.0 (down 63.12% YoY) and the FY2025 annual result came in at $73381.0, down 63.12% from the prior year.
- Treasury Shares was $73381.0 for Q4 2025 at X4 Pharmaceuticals, down from $99232.0 in the prior quarter.
- Across five years, Treasury Shares topped out at $8.4 million in Q1 2024 and bottomed at $73381.0 in Q4 2025.
- A 5-year average of $3.0 million and a median of $1.7 million in 2022 frame the typical range for Treasury Shares.
- Annual changes were most pronounced in 2022 — Treasury Shares jumped 744.24% — and 2025, when it tumbled 98.78%.
- X4 Pharmaceuticals' Treasury Shares stood at $229885.0 in 2021, then soared by 631.05% to $1.7 million in 2022, then surged by 85.58% to $3.1 million in 2023, then tumbled by 93.62% to $198995.0 in 2024, then tumbled by 63.12% to $73381.0 in 2025.
- Business Quant data shows XFOR's Treasury Shares at $73381.0 in Q4 2025, $99232.0 in Q3 2025, and $333264.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | -21,709.08 |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | 265,401.92 |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 19.41 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 5.14 Mn |
| 10 | X4 Pharmaceuticals | 167.90 Mn | -49.15 Mn | 2.20 Mn | 73,381.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 73,381.00 |
| Dec 31, 2025 | 73,381.00 |
| Sep 30, 2025 | 99,232.00 |
| Sep 30, 2025 | 99,232.00 |
| Jun 30, 2025 | 333,264.00 |
| Jun 30, 2025 | 333,264.00 |
| Mar 31, 2025 | 327,972.00 |
| Mar 31, 2025 | 327,972.00 |
| Dec 31, 2024 | 198,995.00 |
| Dec 31, 2024 | 198,995.00 |
| Sep 30, 2024 | 8.12 Mn |
| Sep 30, 2024 | 8.12 Mn |
| Jun 30, 2024 | 8.22 Mn |
| Jun 30, 2024 | 8.22 Mn |
| Mar 31, 2024 | 8.37 Mn |
| Mar 31, 2024 | 8.37 Mn |
| Dec 31, 2023 | 3.12 Mn |
| Dec 31, 2023 | 3.12 Mn |
| Sep 30, 2023 | 5.57 Mn |
| Sep 30, 2023 | 5.57 Mn |